Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
COLPAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.2 pts less than Nifty Midcap 150 and 6.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Colgate-Palmolive (India) reported FY25 net sales of Rs. 5,999 crore, up 6.3% year-on-year, while net profit after tax grew 8.5% to Rs. 1,437 crore. However, Q4 FY25 performance was weak, with net sales declining 1.9% YoY to Rs. 1,452 crore and net profit falling to Rs. 355 crore from Rs. 380 crore a year ago, as management cited softening urban demand and intensified competition. EPS for FY25 stood at Rs. 52.83 versus Rs. 48.67 last year. The Board declared a second interim dividend of Rs. 27 per share, taking the total FY25 dividend to Rs. 51 per share, with payment from June 16, 2025. The 84th AGM is scheduled for July 22, 2025, and the Board also approved a 5-year appointment of M/s. Dholakia & Associates LLP as Secretarial Auditors and revised policies on Related Party Transactions, Insider Trading, and Materiality of Events. The statutory auditors issued an unmodified (clean) opinion on the results.
Full-year results are healthy with solid revenue, profit growth, and a generous dividend payout, which is positive for shareholders. However, the Q4 sales and profit decline signals near-term headwinds from urban demand weakness and competition, which could weigh on FY26 growth expectations.